admin, Author at PsyNews.com

Home Authors Posts by admin

2168 POSTS 0 COMMENTS

https://psynews.com

Pα+ Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine;...

Psychedelic Cannabis + Transpersonal Breathwork Retreat at Holistic TherapeutiX Center, CA

Transpersonal Breathwork Retreat at River Mountain Retreat Center, PA

PT492 – Alien Abductions and Parallel Realities: How Do You Validate...

Prominent At-Home Ketamine Co. Founder, Juan Pablo Cappello, Sounds Alarm, Withdraws...

PT491 – Drug Development, The State of Biotech, and Exploring Non-Hallucinogenic...

Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in...

Psychedelic Integration: How to Weave Your Experiences Into Daily Life

PT490 – Plasticity, the Role of Set and Setting, and the...

1...272829...217 Page 28 of 217

EDITOR PICKS

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin

Pα+ Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine;...

Psychedelic Cannabis + Transpersonal Breathwork Retreat at Holistic TherapeutiX Center, CA

Psychedelic Cannabis + Transpersonal Breathwork Retreat at Holistic TherapeutiX Center, CA

Transpersonal Breathwork Retreat at River Mountain Retreat Center, PA

PT492 – Alien Abductions and Parallel Realities: How Do You Validate...

Prominent At-Home Ketamine Co. Founder, Juan Pablo Cappello, Sounds Alarm, Withdraws...

PT491 – Drug Development, The State of Biotech, and Exploring Non-Hallucinogenic...

Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in...

Psychedelic Integration: How to Weave Your Experiences Into Daily Life

PT490 – Plasticity, the Role of Set and Setting, and the...

EDITOR PICKS

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY